Aspheric intraocular lenses implantation for cataract patients with extreme myopia.
Yanwen FangYi LuAizhu MiaoYi LuoPublished in: ISRN ophthalmology (2014)
Objective. To evaluate the postoperative visual quality of cataract patients with extreme myopia after implantation of aspheric intraocular lenses (IOLs). Methods. Thirty-three eyes were enrolled in this prospectivestudy. Eighteen eyes with an axial length longer than 28 mm were included in the extreme myopia group, and the other 15 eyes were included in the nonextreme myopia group. Phacoemulsification and aspheric IOL implantation were performed. Six months after cataract surgery, best-corrected visual acuity (BCVA), contrast sensitivity, and wavefront aberrations were measured, and subjective visual quality was assessed. Results. The BCVA improved significantly after surgery for both groups, and patients in the nonextreme myopia group achieved better postoperative BCVA due to better retinal status of the eyes. The evaluation of contrast sensitivity without glare was the same in both groups, whereas patients in the nonextreme myopia group performed better at intermediate spatial frequencies under glare conditions. The two groups did not show a significant difference in high-order aberrations. With regard to subjective visual quality, the composite scores of both groups did not differ significantly. Conclusions. Aspheric IOLs provided good visual outcomes in cataract patients with extreme myopia. These patients should undergo careful evaluation to determine the maculopathy severity level before surgery.
Keyphrases
- cataract surgery
- end stage renal disease
- optical coherence tomography
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- optic nerve
- climate change
- prognostic factors
- magnetic resonance imaging
- patients undergoing
- type diabetes
- gene expression
- patient reported outcomes
- metabolic syndrome
- copy number
- sleep quality
- physical activity
- percutaneous coronary intervention
- computed tomography
- glycemic control